INGENITO GARY
Insider CIK 1279473 · CPRX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-05-14 | 2025-05-15 | 44,000 | — | $0 | 546,282 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-05-14 | 2025-05-15 | 44,000 | $23.63 | $1.04M | 68,873 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-05-14 | 2025-05-15 | 44,000 | $4.64 | $204.2K | 112,873 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-05-13 | 2025-05-15 | 200,000 | — | $0 | 590,282 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-05-13 | 2025-05-15 | 200,000 | $3.42 | $684.0K | 268,873 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-05-13 | 2025-05-15 | 200,000 | $23.68 | $4.74M | 68,873 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-03-06 | 2025-03-07 | 180,096 | — | $0 | 790,282 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-03-06 | 2025-03-07 | 180,096 | $2.24 | $403.4K | 248,969 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-03-06 | 2025-03-07 | 180,096 | $21.67 | $3.90M | 68,873 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-03-05 | 2025-03-07 | 44,904 | — | $0 | 970,378 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-03-05 | 2025-03-07 | 44,904 | $2.24 | $100.6K | 113,777 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-03-05 | 2025-03-07 | 44,904 | $22.09 | $991.9K | 68,873 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-02-14 | 2025-02-19 | 10,000 | — | $0 | 1,015,282 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-02-14 | 2025-02-19 | 2,435 | — | $0 | 68,873 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-02-14 | 2025-02-19 | 10,000 | — | $0 | 71,308 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-27 | 2024-12-31 | 9,000 | — | $0 | 1,025,282 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-12-27 | 2024-12-31 | 3,541 | — | $0 | 61,308 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-27 | 2024-12-31 | 9,000 | — | $0 | 64,849 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 7,349 | — | $0 | 1,034,282 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 7,349 | — | $0 | 58,740 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-12-09 | 2024-12-11 | 2,891 | — | $0 | 55,849 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-27 | 2024-11-29 | 12,000 | — | $0 | 1,041,631 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-27 | 2024-11-29 | 8,631 | $22.74 | $196.3K | 54,760 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-27 | 2024-11-29 | 12,000 | $4.01 | $48.1K | 63,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-27 | 2024-11-29 | 3,369 | $22.67 | $76.4K | 51,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 125,696 | — | $0 | 1,038,271 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 15,360 | — | $0 | 1,053,631 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-20 | 2024-11-22 | 38,000 | — | $0 | 912,575 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-20 | 2024-11-22 | 38,000 | $4.01 | $152.4K | 89,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-20 | 2024-11-22 | 38,000 | $21.20 | $805.6K | 51,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-08-09 | 2024-08-13 | 100,000 | — | $0 | 950,575 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-08-09 | 2024-08-13 | 100,000 | $4.01 | $401.0K | 151,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-08-09 | 2024-08-13 | 100,000 | $18.04 | $1.80M | 51,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-06-05 | 2024-06-07 | 80,000 | — | $0 | 1,050,575 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-06-05 | 2024-06-07 | 80,000 | $4.01 | $320.8K | 131,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-06-05 | 2024-06-07 | 80,000 | $16.16 | $1.29M | 51,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-02-15 | 2024-02-16 | 10,000 | — | $0 | 1,130,575 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-02-15 | 2024-02-16 | 2,435 | — | $0 | 51,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-15 | 2024-02-16 | 10,000 | — | $0 | 53,826 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 9,000 | — | $0 | 1,140,575 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-12-27 | 2023-12-29 | 3,541 | — | $0 | 43,826 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 9,000 | — | $0 | 47,367 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 22,049 | — | $0 | 1,149,575 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 153,526 | — | $0 | 1,127,526 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-06 | 2023-12-08 | 50,000 | — | $0 | 974,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-12-06 | 2023-12-08 | 50,000 | $14.02 | $701.0K | 38,367 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-06 | 2023-12-08 | 50,000 | $1.13 | $56.5K | 88,367 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 10,000 | — | $0 | 1,024,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 10,000 | — | $0 | 40,802 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-02-15 | 2023-02-17 | 2,435 | — | $0 | 38,367 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 93,000 | — | $0 | 1,007,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 27,000 | — | $0 | 1,034,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-12-06 | 2022-12-08 | 14,667 | — | $0 | 914,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-12-06 | 2022-12-08 | 5,918 | $16.85 | $99.7K | 30,802 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-12-06 | 2022-12-08 | 14,667 | — | $0 | 36,720 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-09-14 | 2022-09-16 | 88,000 | — | $0 | 928,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-09-14 | 2022-09-16 | 55,000 | — | $0 | 1,016,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-14 | 2022-09-16 | 88,000 | $15.69 | $1.38M | 22,053 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-09-14 | 2022-09-16 | 55,000 | $4.01 | $220.6K | 77,053 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-14 | 2022-09-16 | 55,000 | $15.65 | $860.8K | 22,053 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-09-14 | 2022-09-16 | 88,000 | $4.64 | $408.3K | 110,053 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-06-22 | 2022-06-23 | 6,152 | — | $0 | 1,071,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-06-22 | 2022-06-23 | 6,152 | $4.13 | $25.4K | 28,205 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-06-22 | 2022-06-23 | 6,152 | $6.61 | $40.7K | 22,053 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-06-21 | 2022-06-23 | 143,848 | — | $0 | 1,077,819 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-06-21 | 2022-06-23 | 143,848 | $6.60 | $949.4K | 22,053 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-06-21 | 2022-06-23 | 143,848 | $4.13 | $594.1K | 165,901 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 30,000 | — | $0 | 1,221,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 135,000 | — | $0 | 1,191,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-12-07 | 2021-12-08 | 14,667 | — | $0 | 1,056,667 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2021-12-07 | 2021-12-08 | 3,612 | $6.99 | $25.2K | 22,053 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-12-07 | 2021-12-08 | 14,667 | — | $0 | 25,665 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-30 | 2021-01-04 | 200,000 | — | $0 | 1,071,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2020-12-22 | 2020-12-28 | 14,666 | — | $0 | 871,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2020-12-22 | 2020-12-28 | 14,666 | — | $0 | 14,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2020-12-22 | 2020-12-28 | 3,668 | $3.45 | $12.7K | 10,998 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2019-12-05 | 2019-12-06 | 150,000 | $4.82 | $723.0K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2019-12-04 | 2019-12-06 | 150,000 | — | $0 | 886,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2019-12-04 | 2019-12-06 | 150,000 | $2.53 | $379.5K | 150,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 44,000 | — | $0 | 1,036,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 132,000 | — | $0 | 992,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2019-11-27 | 2019-11-27 | 100,000 | — | $0 | 860,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2019-11-27 | 2019-11-27 | 100,000 | $1.13 | $113.0K | 100,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2019-11-27 | 2019-11-27 | 100,000 | $4.66 | $466.0K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2019-11-21 | 2019-11-22 | 100,000 | $4.50 | $450.0K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2019-11-20 | 2019-11-22 | 100,000 | — | $0 | 960,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2019-11-20 | 2019-11-22 | 100,000 | $0.79 | $79.0K | 100,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 75,000 | — | $0 | 1,060,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 75,000 | — | $0 | 985,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 75,000 | — | $0 | 910,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 95,000 | — | $0 | 740,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 95,000 | — | $0 | 645,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 95,000 | — | $0 | 835,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 500,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 550,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 450,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 50,000 | — | $0 | 350,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 50,000 | — | $0 | 400,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 50,000 | — | $0 | 250,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 50,000 | — | $0 | 300,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 50,000 | — | $0 | 200,000 | SEC↗ |